1-2 of 2
Bikash Verma, MD DVM
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Studies Assessing the Safety and Clinical Activity of Multiple Doses of a NKG2D-Based CAR-T Therapy, Cyad-01, in Acute Myeloid Leukemia

Jason B. Brayer, PhDMD, David A Sallman, MD, Tessa Kerre, MD, Xavier Poire, MD, Violaine Havelange, Philippe Lewalle, MD, Eunice S. Wang, MD, Dominik Selleslag, MD, Sebastien Anguille, MD, Yves Beguin, MD PhD, Enkhtsetseg Purev, MD PhD, Ahmad-Samer Al-Homsi, MD, Doreen Dekker, PhD, Eytan Breman, Panagiota A. Sotiropoulou, PhD, Sarah Snykers, PhD, Nathalie Braun, Caroline Lonez, PhD, Bikash Verma, MD DVM, Frédéric F. Lehmann, MD, Marco L. Davila, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1398.
https://doi.org/10.1182/blood-2018-99-114747
Published: 2018
Journal Articles

Remissions in Relapse/Refractory Acute Myeloid Leukemia Patients Following Treatment with NKG2D CAR-T Therapy without a Prior Preconditioning Chemotherapy

David A Sallman, MD, Tessa Kerre, MD, Xavier Poire, MD, Violaine Havelange, Philippe Lewalle, MD, Marco L. Davila, MD PhD, Eunice S. Wang, MD, Doreen Dekker, PhD, Sarah Snykers, PhD, Panagiota A. Sotiropoulou, PhD, Eytan Breman, Nathalie Braun, Caroline Lonez, PhD, Bikash Verma, MD DVM, Frédéric F. Lehmann, MD, Jason B. Brayer, PhDMD
Journal: Blood
Blood (2018) 132 (Supplement 1): 902.
https://doi.org/10.1182/blood-2018-99-111326
Published: 2018